This review encompasses a discussion of the molecular markers in NC-AML which are mutations (NPM1, FLT3, MLL-PTD, CEPBα) and those that are a function of over-expression (BAALC, MN1, ERG-1, AF1q). This evidence concerns the gene BAALC and acute myeloid leukemia.